First Pass

91 stories from 18 sources

The week in Mergers and Acquisitions

Paramount-Warner Deal Turns Into a Regulatory Standoff

July 2026

Week’s Recap

Click on a headline to see stories that shaped it.

Threads

Stories that evolved over the week.

7 threads

Defined the week

Paramount-Warner Faces Prolonged Delay

A judge first blocked Paramount’s Warner Bros. Discovery acquisition, then extended the order before Paramount agreed to pause the transaction. The outside closing date could stretch to June 2027, increasing execution costs and termination risk.

17 stories, Jul 20 to 24
Defined the week

Prologis Escalates Segro Takeover

Segro rejected repeated approaches while disputing the bidder’s valuation assumptions, but Prologis ultimately raised its offer to about £14 billion and called it best and final. The contest now puts direct pressure on Segro’s board and shareholders.

5 stories, Jul 20 to 22
Major

Private Capital Targets Large Platforms

Institutional and private-capital buyers pursued large platforms across industrial real estate, infrastructure, corporate credit, and wealth management. Competing bids and large portfolio transfers showed continued appetite for recurring fees, hard assets, and control of operating platforms.

5 stories, all week
Major

Regulators Complicate Deal Timelines

The possible EU review of Apollo’s easyJet bid showed how ownership rules can narrow the buyer pool, while the Justice Department signaled a more targeted approach to merger investigations. Together, the developments point to a regulatory process that may become more focused but remains capable of disrupting transactions.

3 stories, Jul 22 to 23
Major

UK Takeover Wave Gathers Force

UK-listed companies attracted more than $60 billion in takeover value after OCS agreed to buy Mitie, reinforcing concern that public companies are becoming targets for private capital. The broader use of bear-hug tactics added pressure to the UK market’s contested-deal environment.

3 stories, Jul 21
Notable

Stripe Pursues OpenRouter

Stripe’s potential acquisition of OpenRouter appeared on successive days at a valuation near $10 billion, with terms still unsettled. The deal would extend Stripe from payments into AI infrastructure and distribution.

2 stories, Jul 23 to 24
Notable

Pharma Drives Biotech Deal Surge

Drugmakers pushed biotech dealmaking to record levels as patent expirations created pressure to replace blockbuster medicines. Buyers concentrated on late-stage assets and platforms capable of supporting multiple products.

1 story, Jul 21

Day’s Recap

Dive deeper into the days that shaped this week